Overview of Dr. Parikh
I am a Board Certified Interventional Cardiologist specializing in valvular and coronary disease. Procedures I perform include percutaneous coronary interventions, transcatheter aortic/mitral valve replacements, transcatheter mitral valve repair, patent foramen ovale/atrial septal defect closures, etc. My research interests deal with valvular heart disease, acute coronary syndromes, and cardiac arrest. I am a Fellow of the American College of Cardiology, American Heart Association, and Society of Coronary Angiography and Interventions.
Office
Stony Brook University Medical Center
Health Sciences Center T16-080
Stony Brook, NY 11794
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Advanced Interventional Cardiology/Valvular and Structural Heart Disease Fellowship, 2014 - 2015
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Interventional Cardiology, 2013 - 2014
- Stony Brook Medicine/University HospitalFellowship, Cardiovascular Disease, 2009 - 2013
- Stony Brook UniversityMPH, Evaluative Sciences, 2009 - 2012
- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2006 - 2009
- Stony Brook University Health Sciences Center School of MedicineClass of 2006
- New York UniversityBA, Biochemistry , Cum Laude, 1999 - 2002
Certifications & Licensure
- NY State Medical License 2009 - 2025
- NJ State Medical License 2009 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 6 citationsThe effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis.Muhammad Shariq Usman, James L Januzzi, Stefan D Anker, Ali Salman, Puja B Parikh
European Journal of Heart Failure. 2024-02-01 - 31 citationsIs There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: “Window” Analysis From the ADAPT-DES Study (A...Ajay J. Kirtane, Puja B. Parikh, Thomas Stuckey, Ke Xu, Bernhard Witzenbichler
JACC. Cardiovascular Interventions. 2015-12-28 - 72 citationsTranscatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve StenosisRon Waksman, Paige Craig, Rebecca Torguson, Federico M. Asch, Gaby Weissman
JACC. Cardiovascular Interventions. 2020-05-11
Press Mentions
- National and International Experts at Long Island Heart ConferenceJune 21st, 2018
- Veterans Heart Patients with Depression Face Difficulties Affording HealthcareApril 19th, 2017
- Depressed Veterans with Heart Disease Face Financial Barriers to CareApril 10th, 2017
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Hindi, Gujarati
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: